Interaction of toxic and non-toxic HypF-N oligomers with lipid bilayers investigated at high resolution with atomic force microscopy

Oncotarget

Volumn 7, Issue 29, 2016, Pages 44991-45004

  Oropesa Nuñez, Reinier ^a,b   Seghezza, Silvia ^a   Dante, Silvia ^a   Diaspro, Alberto ^a,b   Cascella, Roberta ^c   Cecchi, Cristina ^c   Stefani, Massimo ^c   Chiti, Fabrizio ^c   Canale, Claudio ^a  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

AFM; Amyloid oligomers; Ganglioside GM1; Protein aggregation; Protein misfolding

Indexed keywords

BACTERIAL PROTEIN; GANGLIOSIDE GM1; HYPF N PROTEIN; MEMBRANE LIPID; OLIGOMER; UNCLASSIFIED DRUG; ESCHERICHIA COLI PROTEIN; HYPF PROTEIN, E COLI; TRANSFERASE;

ARTICLE; ATOMIC FORCE MICROSCOPY; CELL MEMBRANE; CYTOTOXICITY; LIPID BILAYER; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; PROTEIN STRUCTURE; ANIMAL; CHEMISTRY; HUMAN;

ANIMALS; CARBOXYL AND CARBAMOYL TRANSFERASES; ESCHERICHIA COLI PROTEINS; G(M1) GANGLIOSIDE; HUMANS; LIPID BILAYERS; MEMBRANE LIPIDS; MICROSCOPY, ATOMIC FORCE;

EID: 84979948625     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10449     Document Type: Article

References (64)

1. Stefani M, Dobson CM. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med. 2003; 81: 678-699.
2. Selkoe DJ. Folding proteins in fatal ways. Nature. 2003; 426: 900-905.
3. Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci. 2003; 4: 49-60.
4. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006; 75: 333-366.
5. Bemporad F, Chiti F. Protein Misfolded Oligomers: Experimental Approaches, Mechanism of Formation, and Structure-Toxicity Relationships. Chem Biol. 2012; 19: 315-327.
6. Mucke L, Selkoe DJ. Neurotoxicity of Amyloid β-Protein: Synaptic and Network Dysfunction. Cold Spring Harb Perspect Med. 2012; 2: a006338.
7. Buell AK, Galvagnion C, Gaspar R, Sparr E, Vendruscolo M, Knowles TPJ, Linse S, Dobson CM. Solution conditions determine the relative importance of nucleation and growth processes in a-synuclein aggregation. Proc Natl Acad Sci U S A. 2014; 111: 7671-7676.
8. Cohen SIA, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, Otzen DE, Vendruscolo M, Dobson CM, Knowles TPJ. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A. 2013; 110: 9758-9763.
9. Martins IC, Kuperstein I, Wilkinson H, Maes E, Vanbrabant M, Jonckheere W, Van Gelder P, Hartmann D, D'Hooge R, De Strooper B, Schymkowitz J, Rousseau F. Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J. 2008; 27: 224-233.
10. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 2002; 416: 507-511.
11. Bucciantini M, Calloni G, Chiti F, Formigli L, Nosi D, Dobson CM, Stefani M. Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem. 2004; 279: 31374-31382.
12. Cecchi C, Baglioni S, Fiorillo C, Pensalfini A, Liguri G, Nosi D, Rigacci S, Bucciantini M, Stefani M. Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates. J Cell Sci. 2005; 118: 3459-3470.
13. Baglioni S, Casamenti F, Bucciantini M, Luheshi LM, Taddei N, Chiti F, Dobson CM, Stefani M. Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci. 2006; 26: 8160-8167.
14. Campioni S, Mannini B, Zampagni M, Pensalfini A, Parrini C, Evangelisti E, Relini A, Stefani M, Dobson CM, Cecchi C, Chiti F. A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol. 2010; 6: 140-147.
15. Zampagni M, Cascella R, Casamenti F, Grossi C, Evangelisti E, Wright D, Becatti M, Liguri G, Mannini B, Campioni S, Chiti F, Cecchi C. A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells. J Cell Mol Med. 2011; 15: 2106-2116.
16. Evangelisti E, Cecchi C, Cascella R, Sgromo C, Becatti M, Dobson CM, Chiti F, Stefani M. Membrane lipid composition and its physicochemical properties define cell vulnerability to aberrant protein oligomers. J Cell Sci. 2012; 125: 2416-2427.
17. Mannini B, Cascella R, Zampagni M, van Waarde-Verhagen M, Meehan S, Roodveldt C, Campioni S, Boninsegna M, Penco A, Relini A, Kampinga HH, Dobson CM, Wilson MR, et al. Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers. Proc Natl Acad Sci USA. 2012; 109: 12479-12484.
18. Tatini F, Pugliese AM, Traini C, Niccoli S, Maraula G, Ed Dami T, Mannini B, Scartabelli T, Pedata F, Casamenti F, Chiti F. Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N. Neurobiol Aging. 2013; 34: 2100-2109.
19. Mannini B, Mulvihill E, Sgromo C, Cascella R, Khodarahmi R, Ramazzotti M, Dobson CM, Cecchi C, Chiti F. Toxicity of Protein Oligomers Is Rationalized by a Function Combining Size and Surface Hydrophobicity. ACS Chem Biol. 2014; 9: 2309-2317.
20. Chiti F, Bucciantini M, Capanni C, Taddei N, Dobson CM, Stefani M. Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N-terminal domain. Protein Sci. 2001; 10: 2541-2547.
21. Relini A, Torrassa S, Rolandi R, Gliozzi A, Rosano C, Canale C, Bolognesi M, Plakoutsi G, Bucciantini M, Chiti F, Stefani M. Monitoring the process of HypF fibrillization and liposome permeabilization by protofibrils. J Mol Biol. 2004; 338: 943-957.
22. Marcon G, Plakoutsi G, Canale C, Relini A, Taddei N, Dobson CM, Ramponi G, Chiti F. Amyloid formation from HypF-N under conditions in which the protein is initially in its native state. J Mol Biol. 2005; 347: 323-335.
23. Campioni S, Mossuto MF, Torrassa S, Calloni G, de Laureto PP, Relini A, Fontana A, Chiti F. Conformational properties of the aggregation precursor state of HypF-N. J Mol Biol. 2008; 379: 554-567.
24. Cascella R, Conti S, Tatini F, Evangelisti E, Scartabelli T, Casamenti F, Wilson MR, Chiti F, Cecchi C. Extracellular chaperones prevent Aβ42-induced toxicity in rat brains. Biochim Biophys Acta-Mol Basis Dis. 2013; 1832: 1217-1226.
25. Bucciantini M, Rigacci S, Berti A, Pieri L, Cecchi C, Nosi D, Formigli L, Chiti F, Stefani M. Pattern of cell death triggered in two different cell lines by HypF-N prefibrillar aggregates. FASEB J. 2005; 19: 437-439.
26. Cecchi C, Stefani M. The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity. Biophys Chem. 2013; 182: 30-43.
27. Fukunaga S, Ueno H, Yamaguchi T, Yano Y, Hoshino M, Matsuzaki K. GM1 Cluster Mediates Formation of Toxic Aβ Fibrils by Providing Hydrophobic Environments. Biochemistry. 2012; 51: 8125-8131.
28. Matsubara T, Iijima K, Yamamoto N, Yanagisawa K, Sato T. Density of GM1 in Nanoclusters Is a Critical Factor in the Formation of a Spherical Assembly of Amyloid β-Protein on Synaptic Plasma Membranes. Langmuir. 2013; 29: 2258-2264.
29. Hong S, Ostaszewski BL, Yang T, O'Malley TT, Jin M, Yanagisawa K, Li S, Bartels T, Selkoe DJ. Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes. Neuron. 2014; 82: 308-319.
30. De Almeida RFM, Fedorov A, Prieto M. Sphingomyelin/ phosphatidylcholine/cholesterol phase diagram: boundaries and composition of lipid rafts. Biophys J. 2003; 85: 2406-2416.
31. Kucerka N, Liu Y, Chu N, Petrache HI, Tristram-Nagle S, Nagle JF. Structure of Fully Hydrated Fluid Phase DMPC and DLPC Lipid Bilayers Using X-Ray Scattering from Oriented Multilamellar Arrays and from Unilamellar Vesicles. Biophys J. 2005; 88: 2626-2637.
32. Bartels T, Lankalapalli RS, Bittman R, Beyer K, Brown MF. Raftlike Mixtures of Sphingomyelin and Cholesterol Investigated by Solid-State 2H NMR Spectroscopy. J Am Chem Soc. 2008; 130: 14521-14532.
33. Quist A, Doudevski I, Lin H, Azimova R, Ng D, Frangione B, Kagan B, Ghiso J, Lal R. Amyloid ion channels: A common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A. 2005; 102: 10427-10432.
34. Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT. Neurodegenerative disease: Amyloid pores from pathogenic mutations. Nature. 2002; 418: 291.
35. Dante S, Haub T, Steitz R, Canale C, Dencher NA. Nanoscale structural and mechanical effects of β-amyloid (1-42) on polymer cushioned membranes: A combined study by neutron reflectometry and AFM Force Spectroscopy. Biochim Biophys Acta-Biomembr. 2011; 1808: 2646-2655.
36. Tamboli IY, Prager K, Barth E, Heneka M, Sandhoff K, Walter J. Inhibition of Glycosphingolipid Biosynthesis Reduces Secretion of the β-Amyloid Precursor Protein and Amyloid β-Peptide. J Biol Chem. 2005; 280: 28110-28117.
37. Glabe CG, Kayed R. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurol. 2006; 66: S74-S78.
38. Butterfield SM, Lashuel HA. Amyloidogenic proteinmembrane interactions: mechanistic insight from model systems. Angew Chem Int Ed Engl. 2010; 49: 5628-5654.
39. Chi EY, Frey SL, Winans A, Lam KLH, Kjaer K, Majewski J, Lee KYC. Amyloid-beta fibrillogenesis seeded by interface-induced peptide misfolding and self-assembly. Biophys J. 2010; 98: 2299-2308.
40. Aisenbrey C, Borowik T, Byström R, Bokvist M, Lindström F, Misiak H, Sani M-A, Gröbner G. How is protein aggregation in amyloidogenic diseases modulated by biological membranes? Eur Biophys J. 2008; 37: 247-255.
41. Yip C, McLaurin J. Amyloid-β Peptide Assembly: A Critical Step in Fibrillogenesis and Membrane Disruption. Biophys J. 2001; 80: 1359-1371.
42. Suopanki J, Götz C, Lutsch G, Schiller J, Harjes P, Herrmann A, Wanker EE. Interaction of huntingtin fragments with brain membranes-clues to early dysfunction in Huntington's disease. J Neurochem. 2006; 96: 870-884.
43. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, Glabe CG. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem. 2004; 279: 46363-46366.
44. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol. 2003; 4: 552-565.
45. Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem. 2005; 280: 17294-17300.
46. Bojarski L, Herms J, Kuznicki J. Calcium dysregulation in Alzheimer's disease. Neurochem Int. 2008; 52: 621-633.
47. Okada T, Wakabayashi M, Ikeda K, Matsuzaki K. Formation of toxic fibrils of Alzheimer's amyloid β-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. J Mol Biol. 2007; 371: 481-489.
48. Okada T, Ikeda K, Wakabayashi M, Ogawa M, Matsuzaki K. Formation of toxic Abeta(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Abeta(1-40) fibrils. J Mol Biol. 2008; 382: 1066-1074.
49. Choo-Smith L-P, Surewicz WK. The interaction between Alzheimer amyloid β(1-40) peptide and ganglioside GM1-containing membranes. FEBS Lett. 1997; 402: 95-98.
50. Yanagisawa K, Okada A, Suzuki N, Ihara Y. GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. Nat Med. 1995; 1: 1062-1066.
51. Malchiodi-Albedi F, Contrusciere V, Raggi C, Fecchi K, Rainaldi G, Paradisi S, Matteucci A, Santini MT, Sargiacomo M, Frank C, Gaudiano MC, Diociaiuti M. Lipid raft disruption protects mature neurons against amyloid oligomer toxicity. Biochim Biophys Acta-Mol Basis Dis. 2010; 1802: 406-415.
52. Canale C, Torrassa S, Rispoli P, Relini A, Rolandi R, Bucciantini M, Stefani M, Gliozzi A. Natively folded HypF-N and its early amyloid aggregates interact with phospholipid monolayers and destabilize supported phospholipid bilayers. Biophys J. 2006; 91: 4575-4588.
53. Dante S, Haub T, Brandt A, Dencher N. Membrane fusogenic activity of the Alzheimer's peptide Aβ(1-42) demonstrated by small-angle neutron scattering. J Mol Biol. 2008; 376: 393-404.
54. Shaked GM, Kummer MP, Lu DC, Galvan V, Bredesen DE, Koo EH. Aβ induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). FASEB J. 2006; 20: 1254-1256.
55. Li R, Yang L, Lindholm K, Konishi Y, Yue X, Hampel H, Zhang D, Shen Y. Tumor necrosis factor death receptor signaling cascade is required for amyloid-β protein-induced neuron death. J Neurosci. 2004; 24: 1760-1771.
56. Yan S Du, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, et al. RAGE and amyloid-[beta] peptide neurotoxicity in Alzheimer's disease. Nature. 1996; 382: 685-691.
57. Laurén J, Gimbel D, Nygaard H, Gilbert J, Strittmatter S. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature. 2009; 457: 1128-1132.
58. Hou X, Parkington HC, Coleman HA, Mechler A, Martin LL, Aguilar M-I, Small DH. Transthyretin oligomers induce calcium influx via voltage-gated calcium channels. J Neurochem. 2007; 100: 446-457.
59. Pellistri F, Bucciantini M, Relini A, Nosi D, Gliozzi A, Robello M, Stefani M. Nonspecific Interaction of Prefibrillar Amyloid Aggregates with Glutamatergic Receptors Results in Ca(2+) Increase in Primary Neuronal Cells. J Biol Chem. 2008; 283: 29950-29960.
60. De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL. Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-Daspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine. J Biol Chem. 2007; 282: 11590-11601.
61. Calamai M, Evangelisti E, Cascella R, Parenti N, Cecchi C, Stefani M, Pavone F. Single molecule experiments emphasize GM1 as a key player of the different cytotoxicity of structurally distinct Aβ1-42 oligomers. Biochim Biophys Acta-Biomembr. 2016; 1858: 386-392.
62. Arispe N, Pollard H, Rojas E. β-amyloid Ca2+-channel hypothesis for neuronal death in Alzheimer Disease. Mol Cell Biochem. 1994; 140: 119-125.
63. Kagan BL, Ganz T, Lehrer RI. Pore-Forming Toxins and Antimicrobial Polypeptides Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology. 1994; 87: 131-149.
64. Capone R, Jang H, Kotler SA, Kagan BL, Nussinov R, Lal R. Probing Structural Features of Alzheimer's Amyloid-β Pores in Bilayers Using Site-Specific Amino Acid Substitutions. Biochemistry. 2012; 51: 776-785.